CDH2 and neoplasm: CYR61 silencing led to a reduced expression of N-cadherin (− 34%, p = 3 × 10− 6, Fig. 2c-d), and an increased expression of E-cadherin compared to control tumor cells (+ 58%, p = 2 × 10− 13; Fig. 2e-f).